Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.02.18
2011年度业绩快报
2012.02.11
北京市中伦状师事务所关于公司股权激励妄想的执法意见书
2012.02.11
北京市中伦状师事务所关于公司股票期权激励妄想的增补执法意见书
2012.02.11
中国中投证券有限责任公司关于公司预计2012年度关联生意有关事项的核查意见
2012.02.11
关于召开2012年第一次暂时股东大会的通知通告
2012.02.11
中国中投证券有限责任公司关于公司调解召募资金投资项目投资进度有关事项的核查意见
2012.02.11
2012年度预计一样平常关联生意通告
2012.02.11
股票期权激励妄想(草案)修订稿
2012.02.11
关于《深圳市Z6尊龙药业股份有限公司股票期权激励妄想(草案)修订稿》之自力财务照料报告...
2012.02.11
关于调解募投项目投资进度的通告
第一页
上一页
135
136
137
138
139
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】